CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: September 3, 2009
Result type: Reports
Project Number: SR0195-000
Product Line: Reimbursement Review

Generic Name: Golimumab

Brand Name: Simponi

Manufacturer: Centocor Inc.

Therapeutic Area: Arthritis, psoriatic

Indications: Arthritis, psoriatic

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: March 17, 2010

Recommendation Type: List in a similar manner